The total number of records retrieved from this search are 6. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_1115	Virus nameSindbis virus	Virus strainAR339	Virus genome typeRNA	Virus familyTogaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTsukuba University, Japan	Origin of cell lineOvarian cancer cell line	Cell lineHAC-2	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayFluoroscent mesure at 450nm	In-vitro virus concentration0.01MOI	In-vitro result90% cell viablity	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of delivery	Pathway inducedApoptosis induction in cancer cell lines	Immunogenic effectNA	Clinical trialNA	PMID15958641
IDOV_1116	Virus nameSindbis virus	Virus strainAR339	Virus genome typeRNA	Virus familyTogaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTsukuba University, Japan	Origin of cell lineOvarian cancer cell line	Cell lineHAC-2	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayFluoroscent mesure at 450nm	In-vitro virus concentration0.1MOI	In-vitro result60% cell viablity	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of delivery	Pathway inducedApoptosis induction in cancer cell lines	Immunogenic effectNA	Clinical trialNA	PMID15958641
IDOV_1117	Virus nameSindbis virus	Virus strainAR339	Virus genome typeRNA	Virus familyTogaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTsukuba University, Japan	Origin of cell lineOvarian cancer cell line	Cell lineHAC-2	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayFluoroscent mesure at 450nm	In-vitro virus concentration1MOI	In-vitro result30% cell viablity	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of delivery	Pathway inducedApoptosis induction in cancer cell lines	Immunogenic effectNA	Clinical trialNA	PMID15958641
IDOV_1130	Virus nameReovirus	Virus strainwild type	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTsukuba University, Japan	Origin of cell lineOvarian cancer cell line	Cell lineHAC-2	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayFluoroscent mesure at 450nm	In-vitro virus concentration0.01MOI	In-vitro result35% cell viability	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of delivery	Pathway inducedApoptosis induction in cancer cell lines	Immunogenic effectNA	Clinical trialNA	PMID15958641
IDOV_1131	Virus nameReovirus	Virus strainwild type	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTsukuba University, Japan	Origin of cell lineOvarian cancer cell line	Cell lineHAC-2	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayFluoroscent mesure at 450nm	In-vitro virus concentration0.1MOI	In-vitro result25% cell viability	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of delivery	Pathway inducedApoptosis induction in cancer cell lines	Immunogenic effectNA	Clinical trialNA	PMID15958641
IDOV_1132	Virus nameReovirus	Virus strainwild type	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineTsukuba University, Japan	Origin of cell lineOvarian cancer cell line	Cell lineHAC-2	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayFluoroscent mesure at 450nm	In-vitro virus concentration1MOI	In-vitro result10% cell viability	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of delivery	Pathway inducedApoptosis induction in cancer cell lines	Immunogenic effectNA	Clinical trialNA	PMID15958641